APA (7th ed.) Citation

Stepan, A. F., Claffey, M. M., Reese, M. R., Balan, G., Barreiro, G., Barricklow, J., . . . Shaffer, C. L. (2017). Discovery and Characterization of (R)‑6-Neopentyl-2-(pyridin-2-ylmethoxy)-6,7-dihydropyrimido[2,1‑c][1,4]oxazin-4(9H)‑one (PF-06462894), an Alkyne-Lacking Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator Profiled in both Rat and Nonhuman Primates. Journal of medicinal chemistry, 60(18), 7764-7780. https://doi.org/10.1021/acs.jmedchem.7b00604

Chicago Style (17th ed.) Citation

Stepan, Antonia F., et al. "Discovery and Characterization of (R)‑6-Neopentyl-2-(pyridin-2-ylmethoxy)-6,7-dihydropyrimido[2,1‑c][1,4]oxazin-4(9H)‑one (PF-06462894), an Alkyne-Lacking Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator Profiled in Both Rat and Nonhuman Primates." Journal of Medicinal Chemistry 60, no. 18 (2017): 7764-7780. https://doi.org/10.1021/acs.jmedchem.7b00604.

MLA (9th ed.) Citation

Stepan, Antonia F., et al. "Discovery and Characterization of (R)‑6-Neopentyl-2-(pyridin-2-ylmethoxy)-6,7-dihydropyrimido[2,1‑c][1,4]oxazin-4(9H)‑one (PF-06462894), an Alkyne-Lacking Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator Profiled in Both Rat and Nonhuman Primates." Journal of Medicinal Chemistry, vol. 60, no. 18, 2017, pp. 7764-7780, https://doi.org/10.1021/acs.jmedchem.7b00604.